For Immediate Release
May 6, 2008

Richard F. Kyle, MD, Elected to the Exos Corporation Board of Directors

ST. PAUL, Minn. (May 6, 2008) – Exos Corporation is pleased to announce today that Richard F. Kyle M.D., has been elected to join its board of directors.

Dr. Kyle, the past president of the American Academy of Orthopaedic Surgeons (AAOS 2006 – 2007), is currently chairman of the department of orthopaedic surgery at the Hennepin County Medical Center in Minneapolis. He is also professor of orthopaedic surgery at the University of Minnesota and medical director of the university's biomechanics laboratory, specializing in trauma and adult reconstruction orthopaedics.

Dr. Kyle is active in numerous professional organizations and serves on the board of directors for the Midwest Orthopaedic Research Foundation and the Twin Cities Orthopaedic Education Association. He is a founding member and past president of the Orthopaedic Trauma Association and a member of the American Orthopaedic Association, the American Association of Hip and Knee Surgeons and the Orthopaedic Research Society. He has served on many AAOS task forces and committees.

Dr. Kyle, a graduate of Loyola University Chicago Stritch School of Medicine in Maywood, III., has published two books and has authored 17 book chapters and 60 scientific journal articles. He has given more than 300 presentations, both nationally and internationally, on a variety of topics - including fractures of the long bones and major joints, as well as total shoulder, hip and knee replacement.

The recipient of numerous honors and awards, Dr. Kyle has served as a visiting professor at the University of Hong Kong, at the Virginia Commonwealth University (Richmond, Va.), at the Utah School of Medicine (Salt Lake City) and at the University of Colorado Health Sciences Center (Denver). He is an honorary member of the New Zealand Orthopaedic Society and the Argentine Association of Orthopaedics and Traumatology, and has been named a "Top Doctor" by MpIs.St.Paul Magazine for eight consecutive years.

“Dr. Kyle’s outstanding leadership and internationally-recognized expertise in orthopeadic medicine will provide Exos with the professional credibility and clinical perspective necessary during this pivotal stage of our evolution. Over the last year we have been focused primarily on product development of multiple orthopaedic products using our proprietary OrthoFoam technology. Our next big step is the validation phase – testing our products within a clinical setting. Dr. Kyle’s insight and medical judgment is invaluable as we began introducing the medical community to our revolutionary technology said Fariborz Boor Boor, Exos President and CEO.

Exos Corporation, a privately held company and an affiliate of Enova Medical Technologies, is preparing to launch its revolutionary Orthofoam technology – the world’s first completely customizable, adjustable, waterproof and radiolucent casts, splints and braces.

Enova Medical Technologies, a privately held company, is engaged in the development and commercialization of proprietary medical devices and is an experienced provider of product development, manufacturing, and commercialization services for the medical device industry. From Class I to Class III devices, Enova understands the technical challenges of product design, engineering, research and development, and the regulatory steps required to successfully commercializing products. For more information, visit www.enovamedical.com.

CONTACT:
Kerstin March
Enova Medical Technologies
651-773-3181 x28